Anzeige
Mehr »
Mittwoch, 23.09.2026 - Börsentäglich über 12.000 News
Brandneue News liefert jetzt Teil 2 dieser Kupfer-Story
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
157 Leser
Artikel bewerten:
(0)

Nitches, Inc.: Submissions Are In: Over 2,400% Week-Over-Week Growth as The Next 100 Blends Search Remains Open

Nitches Inc. invites supplement founders, creators, health practitioners, trainers, and athletes to score their concepts for free and submit them for consideration through NutraVeri. Selected concepts may receive a public feature and access to manufacturing guidance; qualified products may be considered for retail presentation.

MIAMI, FL / ACCESS Newswire / September 23, 2026 / Nitches Inc. (OTCID:NICH) today announced that founder submissions have begun arriving for The Next 100 Blends, a national search for supplement concepts conducted through its NutraVeri platform. The search remains open, and founders can use NutraVeri's readiness score at no cost.

The initiative is designed for people who have built a formula around a need they know well: an entrepreneur developing a product, a creator responding to questions from an audience, a practitioner who recommends a combination of ingredients, or a trainer or athlete who has refined a supplement routine over time. A concept can be in development or already on the market.

"A promising formula does not have to arrive as a finished brand," said John Morgan, Chief Executive Officer of Nitches Inc. "If you have a concept you believe in, start by scoring it. You can learn where it stands before deciding whether to submit it."

A starting point for founders

NutraVeri's free readiness score evaluates a concept across six dimensions. Founders can begin at nutraveri.com/formulate? without a payment card or account. The score is an informational tool that can help identify questions to address as a product develops; it is not a determination that a product is ready for manufacture or sale.

Founders retain ownership of their submitted concepts. NutraVeri says it will not publish a submission without the founder's written consent. Additional information about its submission commitments is available at nutraveri.com/trust?.

What selection may include

Nitches plans to feature selected concepts one at a time, with each founder's written consent. A feature may introduce the founder and describe the concept's readiness profile. Selected founders may also be invited to explore NutraVeri's U.S. manufacturing pathway, which the Company says includes an FDA-registered facility operating under applicable dietary supplement current good manufacturing practice requirements and minimum order quantities starting at 2,500 units.

Through the Company's commercialization relationships, qualified products may be considered for preparation and presentation to national mass-market retail buyers. Selection is at the Company's discretion. A feature or invitation does not guarantee manufacturing acceptance, retail presentation, placement, purchase orders, or commercial success.

Founders can score a concept at nutraveri.com/formulate?, then email the scored concept and the story behind it to corporate@nutraveri.com for consideration.

About Nitches Inc.

Nitches Inc. (OTCID:NICH) is developing NutraVeri, a product readiness platform for the dietary supplement industry. NutraVeri offers a free six-dimensional readiness score, an ingredient intelligence index, Product Passports, and access to manufacturing, fulfillment, and commercialization pathways intended to help founders evaluate concepts before committing significant capital. Learn more at www.nutraveri.com?.

Media and search submissions

John Morgan
Chief Executive Officer, Nitches Inc.
corporate@nutraveri.com
www.nutraveri.com?

Forward-looking statements

This release contains forward-looking statements, including statements about The Next 100 Blends, future participation, platform use, manufacturing opportunities, retail presentations, and potential commercialization. These statements reflect current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially. Among other factors, the Company may receive fewer qualifying submissions than expected; selected concepts may not be suitable for manufacture or retail presentation; and manufacturers or retailers may decline to work with a product. No product is guaranteed to be selected, manufactured, presented to a retailer, placed in stores, or commercially successful. The Company undertakes no obligation to update these statements except as required by law.

Important disclosures

The FDA does not approve dietary supplements before they are marketed. FDA facility registration does not constitute FDA approval, endorsement, or certification of a facility or product. NutraVeri scores, reports, Product Passports, and related outputs are informational tools; they do not establish regulatory compliance or certify a product's safety, efficacy, or commercial prospects.

Participation in The Next 100 Blends is free. Selection is a discretionary feature and guidance opportunity, not a prize or chance-based contest. Founders retain ownership of submitted concepts, and no submission will be published without the founder's written consent. Participants remain responsible for product development, claim substantiation, labeling, regulatory compliance, and business decisions.

SOURCE: Nitches, Inc.



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/business-and-professional-services/submissions-are-in-over-2-400-week-over-week-growth-as-the-next-1225858

© 2026 ACCESS Newswire
KI-Euphorie kippt - Bei diesen 5 Aktien droht der Crash!
Drei Jahre lang kannten KI-Aktien fast nur eine Richtung: nach oben. Billionenschwere Investitionspläne von Alphabet, Amazon, Meta und Microsoft haben Halbleiter- und Infrastrukturwerte auf immer neue Höhen getrieben. Doch jetzt bekommt die Erfolgsstory gefährliche Risse.

Steigende Anleiherenditen verteuern die Finanzierung, während die gewaltigen KI-Ausgaben zunehmend nicht mehr aus den laufenden Cashflows bezahlt werden können. Gleichzeitig zeigen günstigere chinesische Modelle, dass leistungsfähige KI womöglich mit deutlich weniger Rechenleistung auskommt. Damit wächst die Gefahr, dass heute für Milliarden errichtete Kapazitäten morgen nicht die erhofften Renditen liefern.

Für Anleger könnte das zum Problem werden. Denn treffen steigende Finanzierungskosten auf Überkapazitäten und enttäuschende Cashflows, geraten gerade hoch bewertete KI-Profiteure schnell unter Druck. Aus den größten Gewinnern der vergangenen Jahre könnten so die größten Verlierer der nächsten Korrektur werden.

In unserem aktuellen Spezialreport zeigen wir 5 Aktien, bei denen das Chance-Risiko-Verhältnis jetzt besonders gefährlich erscheint – und bei denen Anleger genauer hinschauen sollten.

Jetzt den kostenlosen Report sichern – bevor die KI-Euphorie ihren nächsten Realitätstest erlebt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.